A Win For Bellerophon Therapeutics, Inc.

Tue, Jul 26, 2022 at 06:58 PM
A Win For Bellerophon Therapeutics, Inc.

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) rocketted at $1.69, representing a gain of 19.9%. On Tue, Jul 26, 2022, BLPH:NASDAQ hit a New 2-Week High of $1.69. From Tue, Jul 12, 2022, the stock recorded 50.00% Up Days and 36.36% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.